PRKAA2 and nonpapillary renal cell carcinoma: For example, the AMPK activator 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) has been shown to inhibit mTORC1 and thus negatively regulate proliferation and survival of multiple types of cancer cells, including ccRCC [7,9].